1 / 4

North American Peptide Therapeutics Market Size, Industry Trends, Share and Forecast 2020-2026

North American peptide therapeutics market is estimated to project a CAGR of 5.1%, during the forecast period. The high per capita healthcare expenditure coupled with the increasing investment in modern healthcare technologies are the key factors that are anticipated to drive the growth of the peptide therapeutics market in the region. Pfizer Inc., Merck & Co. Inc., Eli Lilly, and Co., and GlaxoSmithKline Plc among others are some of the global key players of the peptide therapeutics market operating in the region.

larebomrglobal
Télécharger la présentation

North American Peptide Therapeutics Market Size, Industry Trends, Share and Forecast 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research North American Peptide Therapeutics Market Share, Trends, Size, Research and Forecast 2020-2026 Request Market@ market ------------------------------------------------------------------------------------ a free https://www.omrglobal.com/request-sample/north-american-peptide-therapeutics- sample of our report on North American Peptide Therapeutics Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 78030404

  2. The North American peptide therapeutics market will see a considerable growth of 5.1% during the forecast period. The region has a significant presence of peptide therapeutics manufacturers, with extensive R&D in the peptide therapeutics market. The Peptide Therapeutics Foundation, a not-for-profit 501C (3) was also established in 2008 in the region with the intention to promote R&D of peptide therapeutics. The Foundation and Symposium are supported by global companies such as Ferring Research Institute Inc., AstraZeneca, the PolyPeptide Group, Novo Nordisk, and Zealand Pharma. This is also anticipated to present new growth opportunities for the companies in the region working in the peptide therapeutics market. A full Report of North American Peptide https://www.omrglobal.com/industry-reports/north-american-peptide-therapeutics-market Concerning peptide therapeutics, the number of research and studies has also been increasing. According to the US FDA, as of March 2017, nearly 40 drugs had obtained approval in the US, Europe, and Japan. In addition, 155 peptides were in active clinical development. 2018 had been a decent one for peptides, with the US FDA approving 5 peptides and 1 peptidomimetic, collectively accounting for about 13% of overall drugs accepted that year. Individual targets have rapidly increased in popularity due to the success of a first-in-class peptide, resulting in numerous follow-on research programs pursuing the same mechanism. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/north-american-peptide-therapeutics-market Key questions addressed by the report •What is the market growth rate during the forecast period? •Which segment/region dominates the market in the base year? •Which segment/region will project the fastest growth in the market during the forecast period? •Who is the leader in the market? •How players are addressing challenges to sustain growth? •Where is the investment opportunity? North American Peptide Therapeutics Market – Segmentation By Route of Administration •Oral •Parenteral Therapeutics Market Available at

  3. By Application •Cancer •Metabolic Disorder •Gastrointestinal Disorders •Central Nervous System Disorders •Respiratory Disorders •Others (Kidney Disorder and Autoimmune Disorder) North American Peptide Therapeutics Market – Segmentation by Geography •US •Canada Company Profiles •Amgen, Inc. •AstraZeneca PLC •Bristol Myers Squibb Co. •Eli Lilly and Co. •F. Hoffmann-La Roche Ltd. •GlaxoSmithKline PLC •Merck & Co., Inc. •Novartis International AG •Novo Nordisk A/S •Pfizer Inc. •Sanofi SA •Xenetic Biosciences, Inc. For More Customized Data, Request for Report Customization https://www.omrglobal.com/report- customization/north-american-peptide-therapeutics-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research

  4. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related